PTC Therapeutics Inc
NASDAQ:PTCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
US |
|
LBG Media PLC
LSE:LBG
|
UK |
|
A
|
Albis Leasing AG
XMUN:ALG
|
DE |
|
GCL New Energy Holdings Ltd
F:TJI
|
HK |
|
Bewhere Holdings Inc
XTSX:BEW
|
CA |
|
E
|
Evoke Pharma Inc
F:EV0
|
US |
|
T
|
Toll Brothers Inc
XMUN:TLK
|
US |
|
T
|
Tabcorp Holdings Ltd
F:THL
|
AU |
|
VSE Corp
F:VS3
|
US |
|
P
|
Paycom Software Inc
F:0PY
|
US |
|
N
|
Nikkiso Co Ltd
XMUN:NKO
|
JP |
|
Orient Corp
F:OIT
|
JP |
|
Constellation Software Inc
TSX:CSU
|
CA |
|
S
|
Sun Peak Metals Corp
OTC:SUNPF
|
CA |
Intrinsic Value
Is PTCT undervalued or overvalued?
See the intrinsic value estimate for PTC Therapeutics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
PTCT looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with PTCT’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What PTC Therapeutics Does
PTC Therapeutics is a biotechnology company that focuses on medicines for rare diseases, especially inherited disorders that affect children and small patient groups. It develops drugs meant to treat the root cause of certain genetic conditions, then seeks approval to sell them in the United States and other markets. Its business is narrower than a big drugmaker’s: it concentrates on hard-to-treat diseases where patients have few other options.
- Headquarters
- United States of America US
- Employees
- 991
- IPO date
- Jun 20, 2013
PTC Therapeutics has a narrow economic moat
PTC Therapeutics Inc has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
PTC Therapeutics Inc
Earnings Waterfall
PTC Therapeutics Inc
The intrinsic value for PTC Therapeutics Inc (PTCT) under the Base Case is hidden USD.
Compared with the current market price of 60.675 USD, the stock appears hidden.